Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study

(2021) Bruna Meira et al.   npj Parkinsons Disease

Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance

(2018) Manon Auffret et al.   CLINICAL DRUG INVESTIGATION

Risk factors for non-motor symptoms in Parkinson's disease

(2018) Johan Marinus et al.   LANCET NEUROLOGY

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

(2018) Regina Katzenschlager et al.   LANCET NEUROLOGY

Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients

(2017) Ángel Sesar et al.   JOURNAL OF NEUROLOGY

24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease

(2016) Lucia Ricciardi et al.   MOVEMENT DISORDERS

Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors

(2016) Roongroj Bhidayasiri et al.   PARKINSONISM & RELATED DISORDERS

Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study

(2016) Gustavo Fernández-Pajarín et al.   Journal of Parkinsons Disease

EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

(2014) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

(2013) C Warren Olanow et al.   LANCET NEUROLOGY

Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

(2012) Pablo Martinez-Martin et al.   JOURNAL OF NEUROLOGY

Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease

(2011) K. Ray Chaudhuri et al.   EUROPEAN JOURNAL OF NEUROLOGY

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

(2011) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Parkinson's disease sleep scale-validation of the revised version PDSS-2

(2011) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome

(2010) I. Reuter et al.   ACTA NEUROLOGICA SCANDINAVICA

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)

(2010) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The MoCA: Well-suited screen for cognitive impairment in Parkinson disease

(2010) J. C. Dalrymple-Alford et al.   NEUROLOGY

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

(2008) Pedro J. García Ruiz et al.   MOVEMENT DISORDERS